Manufacturing / Biological Products, Except Diagnostic Substances
Replimune Group, Inc.
REPL
$15.62
+$0.92 (+6.29%)
Price as of Aug 25, 2026 17:01 UTC
1.4 B
Market Cap (Small Cap)
0%
IV Rank
84.0%
Implied Volatility
Nov 04
Next Earnings
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.25
Bullish skew
Implied Volatility
84.0%
0% percentile
IV vs Realized
Options cheap
30d HV 265.7%
Options Heat Map
Delta-risk grid for REPL options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
2 buys
17 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Buy | 126,394 | $1,524,299 | |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Buy | 2,609,946 | $31,475,688 | |
| Aug 10, 2026 | Schwendenman Andrew | Sell | 7,632 | $98,987 | |
| Aug 10, 2026 | Xynos Konstantinos | Sell | 11,447 | $148,468 | |
| Aug 10, 2026 | Hill Emily Luisa | Sell | 11,448 | $148,481 | |
| Aug 10, 2026 | Patel Sushil | Sell | 39,341 | $510,253 | |
| Jun 01, 2026 | Sarchi Christopher | Sell | 12,000 | $110,880 | |
| May 18, 2026 | Astley-Sparke Philip | Sell | 17,657 | $89,698 | |
| May 18, 2026 | Hill Emily Luisa | Sell | 7,812 | $39,685 | |
| May 18, 2026 | Patel Sushil | Sell | 37,324 | $189,606 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 05, 2026 | Q1 2027 | -$0.70 |
Track REPL with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for REPL and your entire portfolio.